1550 related articles for article (PubMed ID: 32195260)
21. Comprehensive analysis of gene expression profiles to identify differential prognostic factors of primary and metastatic breast cancer.
Albogami S
Saudi J Biol Sci; 2022 Jul; 29(7):103318. PubMed ID: 35677896
[TBL] [Abstract][Full Text] [Related]
22. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
23. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
24. Exploration of the immune-related signature and immune infiltration analysis for breast ductal and lobular carcinoma.
Zhang B; Wang Q; Fu C; Jiang C; Ma S
Ann Transl Med; 2019 Dec; 7(23):730. PubMed ID: 32042746
[TBL] [Abstract][Full Text] [Related]
25. Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma.
Jiao F; Sun H; Yang Q; Sun H; Wang Z; Liu M; Chen J
Int J Med Sci; 2020; 17(11):1610-1624. PubMed ID: 32669964
[TBL] [Abstract][Full Text] [Related]
26. Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit.
Chen J; Hou C; Wang P; Yang Y; Zhou D
World Neurosurg; 2019 Dec; 132():e76-e88. PubMed ID: 31518750
[TBL] [Abstract][Full Text] [Related]
27. NUDT1 Could Be a Prognostic Biomarker and Correlated with Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Lin Y; Zhang F; Jin Y; Zhong Q; Tan W; Liu J; Wu Z
Appl Bionics Biomech; 2022; 2022():3669296. PubMed ID: 36606241
[TBL] [Abstract][Full Text] [Related]
28. Mining the potential prognostic value of synaptosomal-associated protein 25 (SNAP25) in colon cancer based on stromal-immune score.
Zou J; Duan D; Yu C; Pan J; Xia J; Yang Z; Cai S
PeerJ; 2020; 8():e10142. PubMed ID: 33150073
[TBL] [Abstract][Full Text] [Related]
29. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
Zhai Q; Li H; Sun L; Yuan Y; Wang X
Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
[TBL] [Abstract][Full Text] [Related]
30. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
Qi X; Qi C; Qin B; Kang X; Hu Y; Han W
Front Oncol; 2020; 10():541330. PubMed ID: 33072571
[No Abstract] [Full Text] [Related]
31. Integrated bioinformatics analysis to identify 15 hub genes in breast cancer.
Jin H; Huang X; Shao K; Li G; Wang J; Yang H; Hou Y
Oncol Lett; 2019 Aug; 18(2):1023-1034. PubMed ID: 31423162
[TBL] [Abstract][Full Text] [Related]
32. Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment.
Pu N; Chen Q; Gao S; Liu G; Zhu Y; Yin L; Hu H; Wei L; Wu Y; Maeda S; Lou W; Yu J; Wu W
Ann Transl Med; 2019 Nov; 7(22):645. PubMed ID: 31930046
[TBL] [Abstract][Full Text] [Related]
33. A comprehensive analysis of tumor microenvironment-related genes in colon cancer.
Luo R; Guo W; Wang H
Clin Transl Oncol; 2021 Sep; 23(9):1769-1781. PubMed ID: 33689097
[TBL] [Abstract][Full Text] [Related]
34. Identification of Crucial Genes Associated With Immune Cell Infiltration in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis.
Wang D; Liu J; Liu S; Li W
Front Genet; 2020; 11():342. PubMed ID: 32391055
[TBL] [Abstract][Full Text] [Related]
35. A Five-Gene Signature Based on Stromal/Immune Scores in the Tumor Microenvironment and Its Clinical Implications for Liver Cancer.
Liu X; Niu X; Qiu Z
DNA Cell Biol; 2020 Sep; 39(9):1621-1638. PubMed ID: 32758021
[TBL] [Abstract][Full Text] [Related]
36. Eight hub genes as potential biomarkers for breast cancer diagnosis and prognosis: A TCGA-based study.
Liu N; Zhang GD; Bai P; Su L; Tian H; He M
World J Clin Oncol; 2022 Aug; 13(8):675-688. PubMed ID: 36160462
[TBL] [Abstract][Full Text] [Related]
37. Deciphering Immune-Associated Genes to Predict Survival in Clear Cell Renal Cell Cancer.
Hu D; Zhou M; Zhu X
Biomed Res Int; 2019; 2019():2506843. PubMed ID: 31886185
[TBL] [Abstract][Full Text] [Related]
38. Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer.
Li B; Geng R; Wu Q; Yang Q; Sun S; Zhu S; Xu Z; Sun S
Front Oncol; 2020; 10():333. PubMed ID: 32226776
[TBL] [Abstract][Full Text] [Related]
39. Benefits of Targeted Molecular Therapy to Immune Infiltration and Immune-Related Genes Predicting Signature in Breast Cancer.
Chen F; Fang J
Front Oncol; 2022; 12():824166. PubMed ID: 35317079
[TBL] [Abstract][Full Text] [Related]
40. Mining TCGA database for gene expression in ovarian serous cystadenocarcinoma microenvironment.
Xu Y; Xu Y; Wang C; Xia B; Mu Q; Luan S; Fan J
PeerJ; 2021; 9():e11375. PubMed ID: 33987033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
